title: Exploring protein kinase inhibitors: potentiating gemcitabine efficacy in pancreatic cancer.
authors.forename: Young Bin
authors.initials: YB
authors.lastname: Hong
authors.forename: Jung Soon
authors.initials: JS
authors.lastname: Kim
authors.forename: Yong Weon
authors.initials: YW
authors.lastname: Yi
authors.forename: Yeon-Sun
authors.initials: YS
authors.lastname: Seong
authors.forename: Insoo
authors.initials: I
authors.lastname: Bae
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000494:pharmacology; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000494:pharmacology*; D021441:Carcinoma, Pancreatic Ductal / Q000201:enzymology* / Q000473:pathology; D045744:Cell Line, Tumor; D002470:Cell Survival / Q000187:drug effects; D003841:Deoxycytidine / Q000031:analogs & derivatives / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D019008:Drug Resistance, Neoplasm; D004357:Drug Synergism; D006801:Humans; D020128:Inhibitory Concentration 50; D058990:Molecular Targeted Therapy; D010190:Pancreatic Neoplasms / Q000201:enzymology* / Q000473:pathology; D047428:Protein Kinase Inhibitors / Q000494:pharmacology; D000093542:Gemcitabine
chemical_list: D000964:Antimetabolites, Antineoplastic; D047428:Protein Kinase Inhibitors; D003841:Deoxycytidine; D000093542:Gemcitabine